Contact
The journal Science has sought out Joan Guinovart to hear his opinion about the replacement of Izpisúa at the head of the “Centro de Medicina Regenerativa de Barcelona” (CMRB)—a decision taken by the Governing Board of this organisation last Monday. The director of IRB Barcelona has been in demand by many media channels regarding this news, which was reported by the newspaper “El País” last Wednesday. Guinovart stated that this decision had very little or nothing to do with the cutbacks.
Read the article in Science (2014/01/17)
See statements made by IRB director, Joan Guinovart, in the media about the Izpisúa issue:
2014/01/14
El Punt Avui (PDF in Catalan)
2014/01/15
ABC (PDF in Spanish)
ABC (PDF in Spanish)
Efe Salud (PDF in Spanish)
El Economista (PDF in Spanish)
El Economista (PDF in Spanish)
El País (PDf in Spanish)
Knight Science Journalism (PDF in English and Spanish)
La Información (PDF in Spanish)
Materia (PDF in Spanish)
2014/01/16
ABC (PDF in Spanish)
Deia (PDF in Spanish)
El País (PDf in Spanish)
El Periódico (PDF in Catalan)
La Vanguardia, Editorial (PDF in Catalan)
La Vanguardia (PDF in Catalan)
2014/01/17
Science magazine, News (link)
2014/01/19
Materia (PDF in Spanish)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
